Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

NCT07091942 · clinicaltrials.gov ↗

RECRUITING

Status

1600

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]